AAAAAA

   
Results: 1-9 |
Results: 9
EVALUATION OF NATURAL-KILLER-CELL EXPANSION AND ACTIVATION IN-VIVO WITH DAILY SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS PERIODIC INTERMEDIATE-DOSE PULSING
Authors: MEROPOL NJ BARRESI GM FEHNIGER TA HITT J FRANKLIN M CALIGIURI MA
Citation: Nj. Meropol et al., EVALUATION OF NATURAL-KILLER-CELL EXPANSION AND ACTIVATION IN-VIVO WITH DAILY SUBCUTANEOUS LOW-DOSE INTERLEUKIN-2 PLUS PERIODIC INTERMEDIATE-DOSE PULSING, Cancer immunology and immunotherapy, 46(6), 1998, pp. 318-326
NATURAL-KILLER-CELLS FROM HIV-1(-C CHEMOKINES AND INHIBIT HIV-1 INFECTION() PATIENTS PRODUCE C)
Authors: FEHNIGER TA HERBEIN G YU HX PARA MI BERNSTEIN ZP OBRIEN WA CALIGIURI MA
Citation: Ta. Fehniger et al., NATURAL-KILLER-CELLS FROM HIV-1(-C CHEMOKINES AND INHIBIT HIV-1 INFECTION() PATIENTS PRODUCE C), The Journal of immunology (1950), 161(11), 1998, pp. 6433-6438
DIFFERENTIAL EXPRESSION AND FUNCTION OF L-SELECTIN ON CD56(BRIGHT) AND CD56(DIM) NATURAL-KILLER-CELL SUBSETS
Authors: FREY M PACKIANATHAN NB FEHNIGER TA ROSS ME WANG WC STEWART CC CALIGIURI MA EVANS SS
Citation: M. Frey et al., DIFFERENTIAL EXPRESSION AND FUNCTION OF L-SELECTIN ON CD56(BRIGHT) AND CD56(DIM) NATURAL-KILLER-CELL SUBSETS, The Journal of immunology (1950), 161(1), 1998, pp. 400-408
ULTRA-LOW DOSE INTERLEUKIN-2 THERAPY PROMOTES A TYPE-1 CYTOKINE PROFILE IN-VIVO IN PATIENTS WITH AIDS AND AIDS-ASSOCIATED MALIGNANCIES
Authors: KHATRI VP FEHNIGER TA BAIOCCHI RA YU F SHAH MH SCHILLER DS GOULD M GAZZINELLI RT BERNSTEIN ZP CALIGIURI MA
Citation: Vp. Khatri et al., ULTRA-LOW DOSE INTERLEUKIN-2 THERAPY PROMOTES A TYPE-1 CYTOKINE PROFILE IN-VIVO IN PATIENTS WITH AIDS AND AIDS-ASSOCIATED MALIGNANCIES, The Journal of clinical investigation, 101(6), 1998, pp. 1373-1378
FLT3 LIGAND PROMOTES THE GENERATION OF A DISTINCT CD34(-KILLER-CELL PROGENITOR THAT RESPONDS TO INTERLEUKIN-15() HUMAN NATURAL)
Authors: YU HX FEHNIGER TA FUCHSHUBER P THIEL KS VIVIER E CARSON WE CALIGIURI MA
Citation: Hx. Yu et al., FLT3 LIGAND PROMOTES THE GENERATION OF A DISTINCT CD34(-KILLER-CELL PROGENITOR THAT RESPONDS TO INTERLEUKIN-15() HUMAN NATURAL), Blood, 92(10), 1998, pp. 3647-3657
POTENTIAL ROLE FOR INTERLEUKIN-15 IN THE REGULATION OF HUMAN NATURAL-KILLER-CELL SURVIVAL
Authors: CARSON WE FEHNIGER TA HALDAR S ECKHERT K LINDEMANN MJ LAI CF CROCE CM BAUMANN H CALIGIURI MA
Citation: We. Carson et al., POTENTIAL ROLE FOR INTERLEUKIN-15 IN THE REGULATION OF HUMAN NATURAL-KILLER-CELL SURVIVAL, The Journal of clinical investigation, 99(5), 1997, pp. 937-943
CD56(BRIGHT) NATURAL-KILLER-CELL SUBSETS - CHARACTERIZATION OF DISTINCT FUNCTIONAL-RESPONSES TO INTERLEUKIN-2 AND THE C-KIT LIGAND
Authors: CARSON WE FEHNIGER TA CALIGIURI MA
Citation: We. Carson et al., CD56(BRIGHT) NATURAL-KILLER-CELL SUBSETS - CHARACTERIZATION OF DISTINCT FUNCTIONAL-RESPONSES TO INTERLEUKIN-2 AND THE C-KIT LIGAND, European Journal of Immunology, 27(2), 1997, pp. 354-360
STEM-CELL FACTOR ENHANCES INTERLEUKIN-2-MEDIATED EXPANSION OF MURINE NATURAL-KILLER-CELLS IN-VIVO
Authors: FEHNIGER TA CARSON WE MROZEK E CALIGIURI MA
Citation: Ta. Fehniger et al., STEM-CELL FACTOR ENHANCES INTERLEUKIN-2-MEDIATED EXPANSION OF MURINE NATURAL-KILLER-CELLS IN-VIVO, Blood, 90(9), 1997, pp. 3647-3653
STEM-CELL FACTOR (SCF) ENHANCES INTERLEUKIN-2 (IL-2)-MEDIATED EXPANSION OF MURINE NATURAL-KILLER (NK) CELLS IN-VIVO
Authors: FEHNIGER TA MROZEK E CARSON WE CALIGIURI MA
Citation: Ta. Fehniger et al., STEM-CELL FACTOR (SCF) ENHANCES INTERLEUKIN-2 (IL-2)-MEDIATED EXPANSION OF MURINE NATURAL-KILLER (NK) CELLS IN-VIVO, Blood, 88(10), 1996, pp. 2888-2888
Risultati: 1-9 |